hMMS2 serves a redundant role in human PCNA polyubiquitination
2008

MMS2's Role in PCNA Polyubiquitination

publication Evidence: moderate

Author Information

Author(s): Brun, Chiu, Lockhart, Xiao, Wouters, Gray

Primary Institution: Centre for Cancer Therapeutics, Ottawa Health Research Institute

Hypothesis

MMS2 is essential for PCNA polyubiquitination in mammalian cells.

Conclusion

MMS2 serves a redundant role in the DNA damage tolerance pathway, suggesting the presence of another variant that can compensate for its loss.

Supporting Evidence

  • Knockdown of MMS2 did not affect PCNA polyubiquitination after UV irradiation.
  • Mouse embryonic stem cells lacking MMS2 maintained normal PCNA polyubiquitination.
  • Combined knockdown of MMS2 and UEV1A did not disrupt PCNA polyubiquitination.

Takeaway

MMS2 is like a backup helper for fixing DNA, and even when it's not there, other helpers can still do the job.

Methodology

The study involved siRNA-mediated knockdown of MMS2 and UEV1A in human cells and analysis of PCNA polyubiquitination through immunoblotting.

Limitations

The study does not identify the specific redundant protein that compensates for MMS2.

Digital Object Identifier (DOI)

10.1186/1471-2199-9-24

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication